Holocene Advisors
CVS icon

Holocene Advisors’s CVS Health CVS Stock Holding History

Holocene Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311M Sell
3,001,684
-1,478,441
-33% -$132M 0.7% 27
2026
Q1 		$322M Buy
4,480,125
+511,322
+13% +$39.4M 0.78% 25
2025
Q4 		$315M Buy
3,968,803
+2,300,576
+138% +$181M 0.66% 30
2025
Q3 		$126M Sell
1,668,227
-705,715
-30% -$48.4M 0.29% 92
2025
Q2 		$164M Sell
2,373,942
-3,554,232
-60% -$233M 0.4% 69
2025
Q1 		$402M Buy
5,928,174
+3,292,312
+125% +$197M 1.17% 9
2024
Q4 		$118M Buy
+2,635,862
New +$148M 0.38% 71
2024
Q3 		– Sell
-2,738,805
Closed -$162M – 742
2024
Q2 		$162M Buy
+2,738,805
New +$171M 0.68% 41
2023
Q4 		– Sell
-753,390
Closed -$52.6M – 724
2023
Q3 		$52.6M Buy
+753,390
New +$53.4M 0.23% 133
2023
Q2 		– Sell
-191,016
Closed -$14.2M – 750
2023
Q1 		$14.2M Buy
+191,016
New +$16M 0.07% 222
2021
Q4 		– Sell
-358,197
Closed -$30.4M – 880
2021
Q3 		$30.4M Buy
358,197
+278,690
+351% +$23.3M 0.17% 167
2021
Q2 		$6.63M Sell
79,507
-14,833
-16% -$1.21M 0.04% 286
2021
Q1 		$7.1M Sell
94,340
-172,324
-65% -$12.6M 0.04% 297
2020
Q4 		$18.2M Buy
+266,664
New +$17.3M 0.11% 213
2018
Q3 		– Sell
-7,382
Closed -$475K – 737
2018
Q2 		$475K Sell
7,382
-1,946
-21% -$128K 0.01% 319
2018
Q1 		$580K Buy
+9,328
New +$669K 0.01% 142

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Holocene Advisors's CVS Position: Q2 2026 in Review

Holocene Advisors reduced its CVS Health (CVS) stake by 33% in Q2 2026, selling an estimated $132M and leaving 3,001,684 shares worth $311M. The position accounts for 0.7% of the portfolio, ranked #27.

Holocene Advisors first reported a position in CVS in Q1 2018 and has held it in 16 quarters since. The position peaked at $402M in Q1 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Holocene Advisors held 3,001,684 shares of CVS Health worth $311M as of Q2 2026.
  • Holocene Advisors sold 1,478,441 CVS Health shares in Q2 2026, an estimated $132M.
  • CVS Health made up 0.7% of Holocene Advisors's portfolio in Q2 2026, its #27 holding.
  • Holocene Advisors first reported a position in CVS Health in Q1 2018 and has held it in 16 quarters since.
  • Holocene Advisors's CVS Health position peaked at $402M in Q1 2025.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.